Premium global clinical trial supply experts with ClientPharma: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. Read more information at https://www.clientpharma.com/what-we-do/comparator-drug-sourcing/.
Our highly experienced team is ready to hear from you. Please reach out to us with any questions or clinical supply requirements. We look forward to working with you and helping to make your clinical program a success! We Think of Everything, So You Don’t Have To: ClientPharma’s extensive experience and expertise means we provide both comprehensive and pragmatic guidance; delivering on point and on time – no matter how technically challenging.
Our open and collaborative approach is tailored to you and your patients’ needs for every study. With dedicated points-of-contact and direct access to senior management, you are always in connection with us. Through regular business review meetings and custom KPIs, we never lose sight of what’s important to you, your team and your program. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. With our preferred logistics partners, we offer warehousing solutions and specialist logistics to meet your clinical trial requirements. Global pharma warehousing and distribution capabilities: With our own state-of-the-art pharmaceutical warehouses strategically situated in major European and North American distribution hubs, as well as our global network of partner depots, ClientPharma provides you with your clinical trial supplies precisely where and when you need them. With access to our secure pharmaceutical warehousing, you can be confident in the integrity of your supply chain. All of our high-security storage conforms to strict cGDP guidelines. Find more information at clientpharma.com.
ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.
